Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
3
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
cancer immunotherapy
eli lilly
fda
fremanezumab
medical device
migraine
nivolumab
teva pharmaceutical
abbvie
adalimumab (humira)
What
companies
3
×
new
3
×
approval
drug
arguments
big
bio
biogen’s
biopharmaceutical
biotechs
class
club
commercialized
competitors
continued
convo
crop
decades
drugs
earlier
exceeded
failures
fda
firms
group
haul
ipo
joined
latest
life
littered
make
meeting
met
migraine
million
momentum
nasdaq
nash
neon
Language
Current search:
companies
×
new
×
" raleigh-durham blog main "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M